K01 CA100764/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2005	1
2006	3
2007	5
2008	2
2009	3
2010	5
2011	3
2013	1
2014	1
2016	1
2024	0

1

Karyampudi L, Knutson KL. Karyampudi L, et al. Cancer Biomark. 2010;6(5-6):291-305. doi: 10.3233/CBM-2009-0141. Cancer Biomark. 2010. PMID: 20938089 Review.

2

Tumor immunoediting and immunosculpting pathways to cancer progression.

Reiman JM, Kmieciak M, Manjili MH, Knutson KL. Reiman JM, et al. Semin Cancer Biol. 2007 Aug;17(4):275-87. doi: 10.1016/j.semcancer.2007.06.009. Epub 2007 Jun 26. Semin Cancer Biol. 2007. PMID: 17662614 Free PMC article. Review.

3

CD4 regulatory T cells in human cancer pathogenesis.

Knutson KL, Disis ML, Salazar LG. Knutson KL, et al. Cancer Immunol Immunother. 2007 Mar;56(3):271-85. doi: 10.1007/s00262-006-0194-y. Epub 2006 Jul 4. Cancer Immunol Immunother. 2007. PMID: 16819631 Free PMC article. Review.

4

Immune promotion of epithelial-mesenchymal transition and generation of breast cancer stem cells.

Reiman JM, Knutson KL, Radisky DC. Reiman JM, et al. Cancer Res. 2010 Apr 15;70(8):3005-8. doi: 10.1158/0008-5472.CAN-09-4041. Cancer Res. 2010. PMID: 20395197 Free PMC article. Review.

5

AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells.

Asiedu MK, Beauchamp-Perez FD, Ingle JN, Behrens MD, Radisky DC, Knutson KL. Asiedu MK, et al. Oncogene. 2014 Mar 6;33(10):1316-24. doi: 10.1038/onc.2013.57. Epub 2013 Mar 11. Oncogene. 2014. PMID: 23474758 Free PMC article.

6

Immunoediting of cancers may lead to epithelial to mesenchymal transition.

Knutson KL, Lu H, Stone B, Reiman JM, Behrens MD, Prosperi CM, Gad EA, Smorlesi A, Disis ML. Knutson KL, et al. J Immunol. 2006 Aug 1;177(3):1526-33. doi: 10.4049/jimmunol.177.3.1526. J Immunol. 2006. PMID: 16849459

7

TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype.

Asiedu MK, Ingle JN, Behrens MD, Radisky DC, Knutson KL. Asiedu MK, et al. Cancer Res. 2011 Jul 1;71(13):4707-19. doi: 10.1158/0008-5472.CAN-10-4554. Epub 2011 May 9. Cancer Res. 2011. PMID: 21555371 Free PMC article.

8

Augmented HER-2 specific immunity during treatment with trastuzumab and chemotherapy.

Taylor C, Hershman D, Shah N, Suciu-Foca N, Petrylak DP, Taub R, Vahdat L, Cheng B, Pegram M, Knutson KL, Clynes R. Taylor C, et al. Clin Cancer Res. 2007 Sep 1;13(17):5133-43. doi: 10.1158/1078-0432.CCR-07-0507. Clin Cancer Res. 2007. PMID: 17785568

9

Adoptive T cell therapy of solid cancers.

Knutson KL, Wagner W, Disis ML. Knutson KL, et al. Cancer Immunol Immunother. 2006 Jan;55(1):96-103. doi: 10.1007/s00262-005-0706-1. Epub 2005 Oct 27. Cancer Immunol Immunother. 2006. PMID: 15891880 Free PMC article. Review.

10

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial.

Norell H, Poschke I, Charo J, Wei WZ, Erskine C, Piechocki MP, Knutson KL, Bergh J, Lidbrink E, Kiessling R. Norell H, et al. J Transl Med. 2010 Jun 7;8:53. doi: 10.1186/1479-5876-8-53. J Transl Med. 2010. PMID: 20529245 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year